HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marco Pedrazzi Selected Research

Marco Pedrazzi Research Topics

Disease

4Inflammation (Inflammations)
09/2012 - 03/2008
3Cystic Fibrosis (Mucoviscidosis)
04/2021 - 01/2013
3Neoplasms (Cancer)
01/2016 - 03/2008
2Neuroblastoma
01/2015 - 01/2012
2Wounds and Injuries (Trauma)
05/2010 - 12/2009
1Disease Progression
04/2021
1Neuroinflammatory Diseases
01/2021
1Gliosis
01/2021
1Chronic Disease (Chronic Diseases)
01/2019
1Breast Neoplasms (Breast Cancer)
01/2019
1Brain Neoplasms (Brain Tumor)
01/2019
1Osteosarcoma (Osteogenic Sarcoma)
11/2016
1Melanoma (Melanoma, Malignant)
12/2015
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
11/2014
1Conjunctivitis
06/2011
1Blepharitis
06/2011
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2010
1Glioma (Gliomas)
03/2008
1Glioblastoma (Glioblastoma Multiforme)
03/2008
1Necrosis
03/2008
1Carcinoma (Carcinomatosis)
07/2005

Drug/Important Bio-Agent (IBA)

9HMGB1 Protein (HMG1)IBA
11/2016 - 03/2008
6CalpainIBA
01/2019 - 01/2010
3Proteins (Proteins, Gene)FDA Link
06/2011 - 07/2005
2calpastatinIBA
01/2019 - 11/2014
2CytokinesIBA
06/2011 - 12/2009
1Biomarkers (Surrogate Marker)IBA
04/2021
1Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA
04/2021
1Pharmaceutical PreparationsIBA
04/2021
1PolyaminesIBA
01/2021
1Protein Kinases (Protein Kinase)IBA
01/2016
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
01/2016
1Chemotactic FactorsIBA
12/2015
1PerforinIBA
12/2015
1Natural Killer Cell ReceptorsIBA
12/2015
1Biological ProductsIBA
09/2012
1Glutamic Acid (Glutamate)FDA Link
01/2012
1Nitric Oxide Synthase (NO Synthase)IBA
01/2012
1EnzymesIBA
01/2012
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2012
1AcidsIBA
06/2011
12- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA
12/2009
1Carrier Proteins (Binding Protein)IBA
12/2009
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
12/2009
1A-Form DNA (A-DNA)IBA
12/2009
1Nuclear Proteins (Protein, Nuclear)IBA
03/2008
1Receptor for Advanced Glycation End ProductsIBA
03/2008
1Epidermal Growth Factor (EGF)IBA
07/2005

Therapy/Procedure

1Therapeutics
04/2021
1Immunotherapy
01/2016
1Immunomodulation
12/2015